This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Headquartered in Rye Brook, NY, Xylem Inc. is one of the leading providers of water solutions worldwide. The company is involved in the full water-process cycle, including collection, distribution and returning of water to the environment. It has significant presence in the United States, the Asia Pacific, Europe and various other nations. The company reports business operations under three segmental heads — Water Infrastructure, Sensus and Applied Water.
Here's Why Donaldson (DCI) Shares Are Up Over 22% in 6 Months
by Zacks Equity Research
Donaldson (DCI) benefits from its robust aerospace & defense, and aftermarket end markets. Also, its strong product portfolio, firm focus on innovation and shareholder-friendly measures bode well.
Here's Why Xylem (XYL) Stock Should Grace Your Portfolio
by Zacks Equity Research
Strong demand across end markets, price realization and gradual easing of supply chain disruptions bode well for Xylem (XYL). The company's measures to reward its shareholders are noteworthy.
Lindsay (LNN) to Report Q1 Results: What's in the Cards?
by Zacks Equity Research
Lindsay's (LNN) first-quarter fiscal 2023 results are expected to reflect the impacts of strong demand for irrigation equipment, partially offset by inflation and supply-chain issues.
Crane Holdings (CR) Up 13.6% in 6 Months: What's Driving It?
by Zacks Equity Research
Crane Holdings (CR) is backed by strength in its Payment & Merchandising Technologies segment, investment in technology and shareholder-friendly policies.
Robust Order Level & Buyouts Aid IDEX (IEX) Despite Cost Woes
by Zacks Equity Research
While a robust product portfolio, execution abilities and solid order level bode well for IDEX (IEX), supply-chain constraints are a major headwind.
Should You Invest in the Invesco S&P 500 Equal Weight Industrials ETF (RGI)?
by Zacks Equity Research
Sector ETF report for RGI
Is Invesco S&P 500 Equal Weight Industrials ETF (RGI) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RGI
Why Is Xylem (XYL) Up 7.8% Since Last Earnings Report?
by Zacks Equity Research
Xylem (XYL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why It Is Apt to Retain Xylem (XYL) in Your Portfolio
by Zacks Equity Research
Xylem (XYL) stands to benefit from solid underlying market demand and pricing actions across its businesses. XYL's efforts to reward its shareholders with dividends augur well.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Xylem (XYL) Beats on Q3 Earnings, Improves 2022 Guidance
by Zacks Equity Research
Xylem's (XYL) Q2 results benefit from the solid performance across segments. The company raises its 2022 view owing to strong demand and better price realization.
Xylem (XYL) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Xylem (XYL) delivered earnings and revenue surprises of 19.70% and 3.77%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Xylem (XYL) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Xylem (XYL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Xylem (XYL) to Post Q3 Earnings: Will Cost Woes Mar Results?
by Zacks Equity Research
High raw material costs and supply chain disruptions are likely to have weighed on Xylem's (XYL) Q3 performance. However, strong underlying demand is expected to have aided the company's top line.
Xylem (XYL) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Xylem (XYL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Should You Invest in the Invesco S&P 500 Equal Weight Industrials ETF (RGI)?
by Zacks Equity Research
Sector ETF report for RGI
Key Reasons to Retain the Howmet (HWM) Stock in Your Portfolio
by Zacks Equity Research
Continued recovery in the commercial aerospace end market bodes well for Howmet (HWM). The company's healthy margin performance due to cost-control measures and pricing actions are encouraging.
Honeywell (HON) Introduces Ethanol-to-Jet Fuel Technology
by Zacks Equity Research
Honeywell's (HON) new ethanol-to-jet fuel technology, which can substantially reduce greenhouse gas emissions, is aimed at meeting the growing demand for SAF.
Ingersoll Rand (IR) Acquires Dosatron International for $90M
by Zacks Equity Research
Ingersoll Rand's (IR) Dosatron acquisition expands its digital technology portfolio, opening up opportunities in hydroponics, horticulture and water treatment end markets.
Is Invesco S&P 500 Equal Weight Industrials ETF (RGI) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RGI
Xylem (XYL) Moves to Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Xylem (XYL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Why Is Xylem (XYL) Down 6.4% Since Last Earnings Report?
by Zacks Equity Research
Xylem (XYL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Xylem (XYL) Up 13% in 6 Months: Will the Momentum Continue?
by Zacks Equity Research
Strong demand across end markets, solid backlogs and orders are aiding Xylem's (XYL) performance. The company's consistent measures to reward its shareholders are encouraging.
Xylem (XYL) Beats on Q2 Earnings, Improves 2022 Guidance
by Zacks Equity Research
Xylem's (XYL) Q2 results benefit from strong demand across its end markets and record backlog and order levels. The company raises its 2022 view owing to strong demand and better price realization.
Xylem (XYL) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Xylem (XYL) delivered earnings and revenue surprises of 20% and 4.58%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?